The Competition Commission of Pakistan (CCP) recently approved a major corporate transaction. Lotte Chemical Pakistan Limited (LCPL) will acquire a shareholding in Engro Polymer & Chemicals Limited (EPCL). Engro Corporation Limited is currently selling this specific stake. The CCP officially cleared this acquisition after conducting a thorough Phase-I competition assessment. They executed this required review under the Competition Act, 2010.
First, LCPL operates as a public limited company. It actively manufactures and supplies Purified Terephthalic Acid (PTA) across Pakistan. Manufacturers primarily use PTA as a raw material to produce polyester and polyethylene terephthalate (PET).
On the other hand, EPCL operates as the target company in this deal. It actively manufactures and supplies Polyvinyl Chloride (PVC), caustic soda, hydrogen peroxide, and various other chlor-alkali products.
Market Impact & Competition Analysis
During its formal assessment, the CCP identified PVC, caustic soda, and hydrogen peroxide as the relevant product markets. Furthermore, the Commission designated Pakistan as the relevant geographic market.
Interestingly, LCPL does not operate in any of these identified markets. Moreover, neither Lotte Chemical Pakistan Limited (LCPL) nor its affiliated group companies purchase any products from Engro Polymer & Chemicals Limited (EPCL). Therefore, this proposed transaction creates absolutely zero horizontal or vertical overlap between the merging entities.
Currently, EPCL stands as the sole domestic manufacturer in the local PVC market. However, foreign imports provide an important competitive constraint. Meanwhile, in the specific markets for caustic soda and hydrogen peroxide, EPCL holds comparatively lower market shares. Consequently, it actively competes with other existing market participants.
Final Verdict & Market Benefits
Ultimately, the CCP observed that this proposed acquisition only entails a change in ownership and control. The transaction does not inherently increase the target company’s overall production capacity, total sales, or output. As a result, the deal will not increase market concentration. It will not create new barriers to entry. Additionally, it will not materially enhance the market power of either participating party.
Based on this Phase-I assessment, the Commission successfully concluded its review. They formally declared that the transaction is unlikely to substantially lessen competition. It also will not create or strengthen a dominant position in any relevant market. Accordingly, the CCP officially authorized the deal under Section 31(1)(d)(i) of the Competition Act, 2010.
In conclusion, this timely approval clearly reflects the CCP’s broader ongoing commitment. They actively facilitate investments and corporate transactions. Simultaneously, they carefully ensure that market ownership changes never adversely affect competition, market efficiency, or consumer welfare.